| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.053 | 0.3 |